ArticleEBioMedicine2019

Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease.

LaTonya J Hickson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.